ℹ️
🇬🇧
Search
Search for people relevant for "DOUBLE"
DOUBLE
Person
Class
Person
Publication
Programmes
MUDr. David Alan
Academic staff at Second Faculty of Medicine
32 publications
Publications
publication
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
2019 |
Publication without faculty affiliation
publication
Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
2019 |
Publication without faculty affiliation
publication
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
2018 |
Publication without faculty affiliation
publication
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)
2010 |
Second Faculty of Medicine
publication
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial) [ISRCTN81331696]
2005 |
Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Predictors of long-term survival in patients treated with targeted temperature management after cardiac arrest
2020 |
Faculty of Mathematics and Physics
publication
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
2020 |
Publication without faculty affiliation
publication
Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
2020 |
Publication without faculty affiliation
publication
Pitfalls of anticoagulation therapy in pregnant women with mechanical valve prostheses. The case of two thrombotic events during one pregnancy
2019 |
Publication without faculty affiliation
publication
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
2019 |
Publication without faculty affiliation
Load more publications (22)
Loading network view...